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EVIDENCE OF ELEVATED MUSCLE PROTEIN BREAKDOWN (MPB)
PRECEDES MINOR MUSCLE WASTING IN EARLY COLORECTAL CANCER
S.M. Nyasavajjala, C. Srinath, S. Liptrot, A. Selby, D. Rankin, P. Atherton,
K. Smith, J.P. Williams, J.N. Lund, R. Singh, M.J. Rennie. School of
Graduate Entry Medicine and Health, Derby, University of Nottingham
Background and Aims: Baracos group developed a useful method with
clinical CT images to investigate muscle wasting. We applied this tech-
nique to colorectal cancer patients, in a subset of whom we investigated
muscle metabolism.
Methods: We analysed CT images (psoas major, L-3; gluteus maximus,
coccyx) for patients with colorectal cancers (n ¼ 65,73  11y) and patients
who proved normal on investigation(n ¼ 56,71  11y). In a subset (n ¼
18,74  10y) of the cancer patients, we also characterized muscle metab-
olism by stable-tracer and molecular methods.
Results: In the healthy patients, psoas thickness was 30(28,31) mm
(median (95%CI)) and 31(26,30) mm in cancer patients. Normal gluteus
thickness was 30(31,36) mm; 29(32,38) mm in patients; normal psoas
cross sectional area (CSA) was 2873(2708,3299) mm2 and in patients was
3049(2561,4155) mm2. In metabolism subset, psoas thickness was 30(28,
35) mm, gluteus thickness was 36(32, 38) mm; psoas CSA was 2973(2442,
3074) mm2. Thus in patients with early colorectal cancer signiﬁcant
wasting could not be detected by comparison with age-matched controls.
However, the metabolic subset, despite only minor losses of leg muscle (2–
15 g/day), showed “anabolic resistance” of MPS (fed state: 0.030  0.003
vs. 0.071  0.003 %/h) with no evidence of elevated MPB.
Conclusion: Establishment of muscle metabolic dysfunction precedes
major sarcopenia in colorectal cancer.DICHLOROACETATE INDUCES APOPTOSIS AND CELL-CYCLE ARREST IN
COLORECTAL CANCER CELLS BUT NOT IN NON-CANCEROUS CELLS
B.M. Madhok 1, S. Yeluri 1, S.L. Perry 1, T.A. Hughes 2, D.G. Jayne 1. 1 Section of
Translational Anaesthesia and Surgery, University of Leeds; 2 The Leeds
Institute of Molecular Medicine, University of Leeds
Introduction: Cancer cells undergo increased glycolysis, the so-called
‘Warburg effect’. The aim of this study was to determine if switching
metabolism from glycolysis towards mitochondrial respiration would
preferentially induce apoptosis in colorectal cancer cells and examine the
underlying mechanisms.
Methods: Representative colorectal cancer and non-cancerous cell lines
were treated with Dichloroacetate, a non-speciﬁc inhibitor of pyruvate
dehydrogenase kinase (PDK), which promotes mitochondrial respiration.
Cellular proliferation, apoptosis, cell-cycle proﬁle, mitochondrial
membrane potential (Δjm), and glycolytic metabolism were measured.
Results: 20 mMDichloroacetate did not affect growth of non-cancerous 293
and HB2 cells, but caused signiﬁcant decrease in proliferation of all the cancer
cells; HT29, SW480, and LoVo (p ¼ 0.009), associated with a signiﬁcant
increase in apoptotic cells, and an eight-fold increase in number of cells in G2
phaseamongst cancercells suggesting inductionofG2arrest. The largesteffect
on apoptosis was seen in metastatic LoVo cells with 50 mM Dichloroacetate
resulting in a 21% (95% CI: 9 to 34) increase in the apoptotic fraction. Dichlor-
oacetate reduced lactate levels and decreased Δjm in cancer cells (p¼ 0.043).doi:10.1016/j.ijsu.2010.07.003Conclusions: Dichloroacetate induces apoptosis in colorectal cancer cells
via themitochondrial pathway. Further research investigating inhibition of
speciﬁc isoforms of PDK, known to be differentially upregulated in cancer,
is underway.
NEUTROPHIL-LYMPHOCYTE RATIO – AN INDEPENDENT PREDICTOR OF
SURVIVAL IN BREAST CANCER
A. Hakeem, M. West, E. Stefanidis, R. Hardy, L. Martin. Breast Unit, Aintree
University Hospital NHS Trust, Liverpool
Aims: Higher neutrophil-lymphocyte ratios (NLR) on pre-operative
bloods have been shown to be associated with worse survival after
resection of colorectal and other cancers. This study aimed to determine if
NLR can be used as an independent predictor of survival in breast cancer.
Methods: Retrospective review of curative resection for breast cancer
between Jan 2001–Dec 2003 was performed. Prognostic factors were
evaluated by univariate Kaplan–Meier models and multivariate Cox
regression model of survival to test for independence.
Results: 406 underwent resection. 361 had bloods done pre-operatively
and were included. 357 females and 4 males. Mean age 59.2 (29–95) years.
The median follow-up was 89 (72–108) months. 271 patients had NLR <3
and 90 had NLR >3. Percentage deaths for NLR <3 (n ¼ 57, 21.0%) and NLR
>3 (n¼ 34, 37.8%). Mean survival was 97.4 (94.7–100.3) months in patients
with NLR <3 versus 88.7 (82.1–95.3) months in those with NLR >3. On
multiple regression analysis, NLR remained a signiﬁcant prognostic indi-
cator, after adjusting for NPI (Nottingham Prognostic Index) and other
factors (P ¼ 0.0261, 95% CI ¼ 0.7463–0.9216). On Kaplan-Meier survival
analysis of the subsets of groups [Log-Rank (Mantel-Cox) Chi-Square–
6.211, degree of freedom–1, P ¼ 0.013).
Conclusions: Pre-operative NLR is an independent predictor of survival in
breast cancer in this series.131 I-MIBG, A NOVEL APPROACH IN NEUROBLASTOMA TREATMENT
A.I. Morgan 1, S. Ramzy 2, M. Shehawy 2. 1 Norfolk and Norwich University
Hospital; 2National Cancer Institute, Cairo University
Neuroblastoma is the commonest extra-cranial solid-tumour of peripheral
sympathetic NS in children and leading cause of cancer-related deaths in
childhood(1–4Y). Tumour-cells take up, store and secrete catecholamine
metabolites and express the norepinephrine transporter, making meta-
iodobenzylguanidine (MIBG)-an analogue of norepinephrine- an ideal
tumour-speciﬁc agent for imaging and therapy when labelled with 131I or
123I. This randomised controlled trial presents our experience in using
131I-MIBG upfront therapy in diagnosing and treating Neuroblastoma.
Thirty-four patients had their treatment up-fronted by 3–4 cycles of 131
I-MIBG every 21–28 days guided by haematological recovery (Group A)
followed by ﬁrst-line chemotherapy. Surgical intervention varied accord-
ing to response aiming at complete tumour-clearance. Follow-Up (24–60
Months) and results were compared to the control-group of 36 patients
who had their treatment after a diagnostic 131I-MIBG approach. Group-A
demonstrated an objective response to initial 131I-MIBG therapy of 44.10%,
while group-B missed this response, not only the overall OR. following
completion of three main lines of treatment was signiﬁcantly higher in the
Abstracts / International Journal of Surgery 8 (2010) 501–578514Group-A(p > 0.039) but also the overall survival(p > 0.032). Complete
Surgical-clearance of tumour was achieved at a much higher signiﬁcant
rate in the Group-A(p < 0.032) which would constitute a cornerstone in
improving survival. Side-effects for 131I-MIBG included toxicities in
different patterns, however, complications were generally tolerated and
non-fatal.EXPLOITING WARBURG'S EFFECT FOR CLINICAL GAIN: PDK-3 IS
A POTENTIAL TARGET FOR MITOCHONDRIAL MODULATION IN
COLORECTAL CANCER (CRC)
S. Yeluri 1,2, B. Madhok 1,2, P. Prasad 2, M.J. Alemkunnapuzzha 2, H.L. Thorpe 3,
S.L. Perry 1, T.A. Hughes 1, K.R. Prasad 2, P. Quirke 1, D.G. Jayne 1,2. 1 Leeds
Institute of Molecular Medicine, University of Leeds; 2 St. James\'s
University Hospital, Leeds; 3Clinical Trials Research Unit, University of Leeds
Introduction: Cancers preference for glycolysis, with down-regulation of
mitochondrial respiration, also known as the ‘Warburg effect’, provides
a unique cancer target by modulation of mitochondrial respiration. We
have examined the key regulators of glycolysis and mitochondrial respi-
ration in CRC, to investigate its inﬂuence on outcome, and identify novel
targets for anti-cancer therapy.
Methods: Antibody speciﬁcity was conﬁrmed by western blotting. Tissue
micro-arrays incorporating 280 CRCs were constructed and probed by
immunohistochemistry for markers of glycolysis (HIF1a, LDH5), and
oxidative phosphorylation (PDK isoforms 1-4, PDC subunits E1a, E2).
Expression levels were scored semi-quantitatively, and compared to clin-
icopathological and 5-year survival data.
Results: Poorly differentiated tumours demonstrated signiﬁcantly higher
HIF1a, and lower PDC-E1a expression (p<0.05). High HIF1a, LDH5 and PDK1
expression was associated with high Dukes’ stage (p<0.05). High PDK3 (p ¼
0.022, HR ¼ 1.92, 95% CI:1.1,3.36), and low PDC-E1a (p ¼ 0.022, HR ¼ 1.60,
95% CI:1.1,2.4) expression were independent predictors of poor 5-year
disease free survival, as were glycolytic markers- high HIF1a (p ¼ 0.006, HR
¼ 2.11, 95% CI: 1.24, 3.58), and LDH5 (p¼ 0.041, HR¼ 1.57, 95% CI:1.02, 2.41).
Conclusion: CRCs demonstrating Warburg's effect display aggressive
biology, and are associated with signiﬁcantly worse survival. The PDH/PDK
system plays an important role in regulating Warburg's effect, with PDK3
an attractive anti-cancer target.LIVER ISCHAEMIC PRECONDITIONING REDUCES LIVER ISCHAEMIA
REPERFUSION INJURY ACTING THROUGH NITRIC OXIDE SYNTHASE
INDEPENDENT OF HAEM OXYGENASE-1
G. Datta, B. Ramesh, B.J. Fuller, B.R. Davidson. Royal Free Hospital and
Medical School, London, UK
Introduction: Ischaemia reperfusion injury (IRI) is a major cause of
morbidity in liver transplantation. Haem oxygenase-1 (HO-1) and endo-
thelial nitric oxide (NO) are protective mediators. This study sought
examined the role of eNOS and HO-1 using a robust eNOS knockout model
of ischaemic preconditioning rather than pharmacological agents which
are nonspeciﬁc.
Methods: A murine model of partial hepatic ischaemia(45 min)/reperfu-
sion (2 hr or 24 hr) was used. Groups: sham laporotomy; ischameia
reperfusion (IR) only; IPC with IR in both wild type (C57BL6) and eNOS
knockout mice. Endpoints: Histology, sALT, Western Blot (eNOS, phospho-
eNOS, HO-1) and RT-PCR (HO-1).Results: IR resulted in IRI reﬂected in deranged ALT and histology. This
injury was worse in knockouts than wild types. IPC reduced liver injury in
wild types but this protection was abrogated in knockouts. IRI was asso-
ciated with higher eNOS expression. HO-1 protein was not detected in any
group, but HO-1 mRNA levels were seen in both wild type and knockouts
after 2 hr reperfusion. HO-1 proteinwas detected in IPC and IR groups after
24 hr.
Conclusions: eNOS is a protective mediator of IPC in liver IRI. HO-1
expression is increased in the later stages of IPC and IRI and is not
dependent on eNOS.GENETICS AND SURGICAL OUTCOME: ARE THE TNFa PROMOTER
POLYMORPHISMS -238A/G AND -308A/G IMPORTANT?
Fraser Welsh. University College London
Background: Ability to predict poor outcome after major surgery is
clearly advantageous as treatment can be targeted accordingly. Excessive
inﬂammatory response to surgery has been implicated in determining
poor outcome. Recent studies have focused on the role of inﬂammatory
cytokines; among the most signiﬁcant is TNFa. Several functional poly-
morphisms have been identiﬁed in the TNFa gene. We examined the effect
of major abdominal surgery on TNFa expression and examine the rele-
vance of the TNFa -308A/G and -238A/G polymorphisms to surgery-
induced inﬂammatory responses and outcome.
Methods: Blood was obtained from patients before and 24 hours after
laparotomy for colorectal cancer. Genotypes for the -308A/G and -238A/G
polymorphisms determined from DNA by PCR and restriction enzyme
digestion. Gene transcription levels determined from RNA by RT-PCR.
Plasma TNFa levels were determined by ELISA. Length of hospital stay and
ITU stay determined from patients’ notes.
Results and Conclusions: Colorectal surgery did not signiﬁcantly alter
TNFa transcription at 24 hours (p ¼ 0.36) and did not signiﬁcantly
increase TNFa plasma levels (p ¼ 0.28). The -238A/G or -308A/G
polymorphisms did not signiﬁcantly change transcription or plasma
levels. Lengths of hospital stay were unaffected by genotype. Possession
of a -238A allele increased the likelihood of an ITU stay post-operation
(p ¼ 0.04).POOR NUTRITIONAL INTAKE IN ACUTE FRACTURED NECK OF FEMUR
ADMISSION-IS THIS WELL DESCRIBED CLINICAL PROBLEM STILL
UNDER MANAGED?
Peter J. Dacombe, Rhys G.E. Clement, James Woodard, Opinder
Sahota. University of Nottingham, Division of Orthopaedic and Accident
Surgery
Background: Fractured neck of femurs cause substantial morbidity,
mortality and a huge ﬁnancial burden to the NHS. Nutritional care,
included in intercollegiatemanagement guidelines, is too often overlooked
in clinical practice.
Study Aim: To evaluate protein and energy intake of acute fractured neck
of femur patients depending on admission MMSE, and compare these to
department of health targets. Method: 40 fractured neck of femur
admissions, recruited between December 08-March 09, were put into
three groups depending on admission MMSE. Nutrition screening infor-
mation (mid-arm circumference, grip strength, MUST score) was recorded,
kcal and protein intake were calculated for a three day period.
